Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy

Preliminary Report

Bernardo Rocco, Ottavio de Cobelli, Maria Elena Leon, Mario Ferruti, Mauro G. Mastropasqua, Deliu Victor Matei, Giacomo Gazzano, Fabrizio Verweij, Epifanio Scardino, Gennaro Musi, Bob Djavan, Francesco Rocco

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objectives: The various prostate biopsy methods are usually compared in terms of the diagnosis rate of prostate cancer. However, the prevalence of cancer in patients with a negative prostatic biopsy is not usually known. We determined the sensitivity and detection rate of 12-core transperineal biopsies in patients not previously investigated for prostate cancer. Methods: We performed prostate biopsy in 63 patients (median age 67 years) before radical cystoprostatectomy for high-grade bladder cancer. We then assessed the relationships between biopsy result, prostate cancer in the surgical specimen, and other variables. Results: 17.2% of patients had a positive biopsy and 54% had prostate cancer on definitive histology. Biopsy sensitivity was 32.3% overall, 75% for clinically significant cancers, and 11% for non-significant cancers. Median PSA was 1.2 ng/ml, PSA levels did not correlate with the presence of prostate cancer, the presence of clinically significant cancer, bioptic diagnosis, or prostate volume. Age correlated with risk of cancer. Conclusions: According to autopsy series, the prevalence of prostate cancer is greater than 50% in males older than 60, yet low PSA levels do not reliably indicate disease absence. The sensitivity of double sextant biopsy is unsatisfactory overall (32%), but acceptable (75%) for diagnosing clinically significant cancer.

Original languageEnglish
Pages (from-to)827-833
Number of pages7
JournalEuropean Urology
Volume49
Issue number5
DOIs
Publication statusPublished - May 2006

Fingerprint

Prostate
Biopsy
Prostatic Neoplasms
Neoplasms
Urinary Bladder Neoplasms
Autopsy
Histology

Keywords

  • Clinical significance
  • Needle biopsy
  • Prostate cancer
  • PSA
  • Sensitivity

ASJC Scopus subject areas

  • Urology

Cite this

Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy : Preliminary Report. / Rocco, Bernardo; de Cobelli, Ottavio; Leon, Maria Elena; Ferruti, Mario; Mastropasqua, Mauro G.; Matei, Deliu Victor; Gazzano, Giacomo; Verweij, Fabrizio; Scardino, Epifanio; Musi, Gennaro; Djavan, Bob; Rocco, Francesco.

In: European Urology, Vol. 49, No. 5, 05.2006, p. 827-833.

Research output: Contribution to journalArticle

Rocco, B, de Cobelli, O, Leon, ME, Ferruti, M, Mastropasqua, MG, Matei, DV, Gazzano, G, Verweij, F, Scardino, E, Musi, G, Djavan, B & Rocco, F 2006, 'Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report', European Urology, vol. 49, no. 5, pp. 827-833. https://doi.org/10.1016/j.eururo.2005.12.021
Rocco, Bernardo ; de Cobelli, Ottavio ; Leon, Maria Elena ; Ferruti, Mario ; Mastropasqua, Mauro G. ; Matei, Deliu Victor ; Gazzano, Giacomo ; Verweij, Fabrizio ; Scardino, Epifanio ; Musi, Gennaro ; Djavan, Bob ; Rocco, Francesco. / Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy : Preliminary Report. In: European Urology. 2006 ; Vol. 49, No. 5. pp. 827-833.
@article{e923d5fe8e644ad4a5c3233112bcf867,
title = "Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report",
abstract = "Objectives: The various prostate biopsy methods are usually compared in terms of the diagnosis rate of prostate cancer. However, the prevalence of cancer in patients with a negative prostatic biopsy is not usually known. We determined the sensitivity and detection rate of 12-core transperineal biopsies in patients not previously investigated for prostate cancer. Methods: We performed prostate biopsy in 63 patients (median age 67 years) before radical cystoprostatectomy for high-grade bladder cancer. We then assessed the relationships between biopsy result, prostate cancer in the surgical specimen, and other variables. Results: 17.2{\%} of patients had a positive biopsy and 54{\%} had prostate cancer on definitive histology. Biopsy sensitivity was 32.3{\%} overall, 75{\%} for clinically significant cancers, and 11{\%} for non-significant cancers. Median PSA was 1.2 ng/ml, PSA levels did not correlate with the presence of prostate cancer, the presence of clinically significant cancer, bioptic diagnosis, or prostate volume. Age correlated with risk of cancer. Conclusions: According to autopsy series, the prevalence of prostate cancer is greater than 50{\%} in males older than 60, yet low PSA levels do not reliably indicate disease absence. The sensitivity of double sextant biopsy is unsatisfactory overall (32{\%}), but acceptable (75{\%}) for diagnosing clinically significant cancer.",
keywords = "Clinical significance, Needle biopsy, Prostate cancer, PSA, Sensitivity",
author = "Bernardo Rocco and {de Cobelli}, Ottavio and Leon, {Maria Elena} and Mario Ferruti and Mastropasqua, {Mauro G.} and Matei, {Deliu Victor} and Giacomo Gazzano and Fabrizio Verweij and Epifanio Scardino and Gennaro Musi and Bob Djavan and Francesco Rocco",
year = "2006",
month = "5",
doi = "10.1016/j.eururo.2005.12.021",
language = "English",
volume = "49",
pages = "827--833",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier B.V.",
number = "5",

}

TY - JOUR

T1 - Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy

T2 - Preliminary Report

AU - Rocco, Bernardo

AU - de Cobelli, Ottavio

AU - Leon, Maria Elena

AU - Ferruti, Mario

AU - Mastropasqua, Mauro G.

AU - Matei, Deliu Victor

AU - Gazzano, Giacomo

AU - Verweij, Fabrizio

AU - Scardino, Epifanio

AU - Musi, Gennaro

AU - Djavan, Bob

AU - Rocco, Francesco

PY - 2006/5

Y1 - 2006/5

N2 - Objectives: The various prostate biopsy methods are usually compared in terms of the diagnosis rate of prostate cancer. However, the prevalence of cancer in patients with a negative prostatic biopsy is not usually known. We determined the sensitivity and detection rate of 12-core transperineal biopsies in patients not previously investigated for prostate cancer. Methods: We performed prostate biopsy in 63 patients (median age 67 years) before radical cystoprostatectomy for high-grade bladder cancer. We then assessed the relationships between biopsy result, prostate cancer in the surgical specimen, and other variables. Results: 17.2% of patients had a positive biopsy and 54% had prostate cancer on definitive histology. Biopsy sensitivity was 32.3% overall, 75% for clinically significant cancers, and 11% for non-significant cancers. Median PSA was 1.2 ng/ml, PSA levels did not correlate with the presence of prostate cancer, the presence of clinically significant cancer, bioptic diagnosis, or prostate volume. Age correlated with risk of cancer. Conclusions: According to autopsy series, the prevalence of prostate cancer is greater than 50% in males older than 60, yet low PSA levels do not reliably indicate disease absence. The sensitivity of double sextant biopsy is unsatisfactory overall (32%), but acceptable (75%) for diagnosing clinically significant cancer.

AB - Objectives: The various prostate biopsy methods are usually compared in terms of the diagnosis rate of prostate cancer. However, the prevalence of cancer in patients with a negative prostatic biopsy is not usually known. We determined the sensitivity and detection rate of 12-core transperineal biopsies in patients not previously investigated for prostate cancer. Methods: We performed prostate biopsy in 63 patients (median age 67 years) before radical cystoprostatectomy for high-grade bladder cancer. We then assessed the relationships between biopsy result, prostate cancer in the surgical specimen, and other variables. Results: 17.2% of patients had a positive biopsy and 54% had prostate cancer on definitive histology. Biopsy sensitivity was 32.3% overall, 75% for clinically significant cancers, and 11% for non-significant cancers. Median PSA was 1.2 ng/ml, PSA levels did not correlate with the presence of prostate cancer, the presence of clinically significant cancer, bioptic diagnosis, or prostate volume. Age correlated with risk of cancer. Conclusions: According to autopsy series, the prevalence of prostate cancer is greater than 50% in males older than 60, yet low PSA levels do not reliably indicate disease absence. The sensitivity of double sextant biopsy is unsatisfactory overall (32%), but acceptable (75%) for diagnosing clinically significant cancer.

KW - Clinical significance

KW - Needle biopsy

KW - Prostate cancer

KW - PSA

KW - Sensitivity

UR - http://www.scopus.com/inward/record.url?scp=33644865844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644865844&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2005.12.021

DO - 10.1016/j.eururo.2005.12.021

M3 - Article

VL - 49

SP - 827

EP - 833

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -